Floatz logo

MELIPRAMINE

Polyneuropathy

Odense University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

32 Active assets in the Polyneuropathy cohort.

Asset / SponsorPhaseRating
Pregabalin
University of Rochester
Phase 4A
LIDOCAINE
University of Utah
Phase 4BBB
Nabiximols
VA Office of Research and Development
Phase 3BBB
Eloxatin
Tanta University
Phase 3BBB
LIDOCAINE
University Health Network, Toronto
Phase 3BB

View all 50 →

Same molecule, other indications

MELIPRAMINE is also rated in:

dysthymic disorderDormant
BBB
Indicative ·
75 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
72 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →